We'll be presenting our poster at the 6th World Parkinson Congress this week - abstract: 'Accelerating research on Parkinson’s disease and empowering patients through digital health technologies' - at P24.12 on Wednesday (5th) 11.30CET. See you there! #wpc2023 #parkinsonsresearch

We are delighted to announce that uMed are supporting the UK’s largest research programme, Our Future Health! We are working with our vast network of GP partners to engage volunteers via SMS, inviting them to take part in this revolutionary programme: umed.io/news/company/o…

Health and research tech company uMed has announced that michaeljfox.org has selected its service to support the global expansion of its wide-scale study exploring the link between loss of smell and brain disease htworld.co.uk/news/umed-part… #Parkinsons

We’re delighted to announce that uMed has partnered with The Michael J. Fox Foundation to run its smell test study in the UK, as part of a global programme to explore the link between smell loss and #Parkinsonsdisease. Read more: umed.io/news/company/u… #parkinsonsresearch

Great to see this article published in Healthcare Business Today! uMed's CEO Matt Wilson discusses the untapped potential of harnessing data-led insights to drive personalized, meaningful consumer experiences within the #healthcare sector. healthcarebusinesstoday.com/redefining-pat…

Over 10,000 people are taking part to help understand the risk factors of Parkinson's through the PREDICT-PD Study. Could you join them? The research team at Queen Mary University of London is finding ways to make sure people from all backgrounds are represented. Read more 👇🏾 prksn.uk/4bA9jjc

A research project which aims to identify people at higher risk of #Parkinsons or before the symptoms appear has exceeded its milestone of 10,000 participants, thanks to the support of health and research tech company uMed htworld.co.uk/news/research-… #healthtech

This is great news! The development of therapies like this are critical for the effective management of Parkinson’s symptoms and to ensure a better quality of life for patients. Read more: bbc.co.uk/news/health-68… #parkinsonsdisease #parkinsons #parkinsonsresearch

Our first manuscript from AccessPD, co-authored by Dr. Yun Hsuan Chang from uMed and Professor Alastair Noyce from Queen Mary University of London, is published in the Nature Journal - NPJ Parkinson's Disease. nature.com/articles/s4153…

Our team is ready to attend #IAPRD24 in Lisbon! We're looking forward to catching-up with the #Parkinsonsresearch community and sharing the capabilities of our AccessPD Parkinson's Disease Cohort Study. Discover more here about AccessPD 👉 umed.io/access-cohort-…

📢 We are pleased to announce our partnership with the Global Parkinson’s Genetics Program (GP2) to support expansion of the international genetic initiative.🧬. Read the full press release > umed.io/partners/umed-… #parkinsonsdisease #parkinsonsresearch

ACCESS Cohorts combine #realworldevidence with the power of #patientgenerateddata, providing researchers access to ✅ a rich source of regulatory grade data that can be further augmented with the collection of custom endpoints ✅ datasets in just 3 months #observationalstudies

Check out our latest work supporting the RSVoice #RSV #vaccine studies 👩🏽‍⚕️650 nurse calls made to every CAD/CHF patient ✅ 25% of referred patients were randomised 🥇Supported the top recruiting trial site in the UK with high quality referrals umed.io/case-studies/r…

uMed will be attending the #ESCCongress at the end of the month🫀 Book a meeting with our team to learn how our unique #AccessCMD #Cardiometabolic Cohort combines #realworldevidence with the power of patient-generated data to enable rapid, fit-for-purpose #observationalstudies

Meet us at the #ESCCongress this weekend to learn how uMed's #AccessCMD #Cardiometabolic Cohort combines real-world evidence with the power of patient-generated data to enable rapid, fit-for-purpose observational studies. umed.io/access-cohort-… #cardiology #cardiometabolics

Thank you to everyone who stopped by our poster presentation at #ICTMC2024 this week - you can access a digital copy of the poster here: umed.io/publications/p… A special thanks to Dr.Mark Toshner for talking about uMed and AccessCMD in his presentation yesterday 🙌

uMed will be joining the #ILD research community at #ICLAF2024 this weekend! 🫁 Don’t miss Olina's poster presentation on Tuesday 15th - “The role of e-registries in advancing Interstitial Lung Disease research; insights from the #AccessILD registry in the UK” [poster: PP140]

The challenges in obesity research are significant, but the opportunities for innovation are equally profound. pharmexec.com/view/future-of…

📢New Partnership Announcement at #ISPOREurope! We are excited to partner with Decisive Consulting, a Herspiegel company, to offer a unique consultancy service that addresses critical evidence gaps, shaping #marketaccess strategies and demonstrating value to #HTA bodies. umed.io/company/decisi…

uMed's AccessPD Interactive #Parkinson’s Registry has surpassed 1,000 participants! 🎉 A milestone for advancing research, exploring novel endpoints, and driving insights toward new treatments. Learn more: umed.io/company/access…